SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-013641
Filing Date
2022-08-15
Accepted
2022-08-15 17:04:14
Documents
12
Period of Report
2022-08-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220815x8k.htm   iXBRL 8-K 42409
  Complete submission text file 0001558370-22-013641.txt   157850

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20220815.xsd EX-101.SCH 3041
3 EX-101.LAB tmb-20220815_lab.xml EX-101.LAB 15272
4 EX-101.PRE tmb-20220815_pre.xml EX-101.PRE 9663
6 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220815x8k_htm.xml XML 4675
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 221166552
SIC: 2834 Pharmaceutical Preparations